News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
UK and Swedish researchers used a Mendelian randomization approach to study the association between serum calcium and heart disease and heart attack risk.
Using data from the UK Biobank, a Harvard Medical School-led team of researchers has uncovered 15 new loci associated with coronary artery disease.
The two firms are offering a combined genetic disease risk and pharmacogenomic analysis that covers 49 conditions and about 220 medications.
A Canadian research team has reported beta-blockers alter the gene expression changes that take place in a mouse model of heart failure.
The international team says its findings may explain the evolutionary reasons for the maintenance of coronary artery disease in human populations.
